Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RLAY · against 270 other Healthcare companies of similar size
Ranked #21 of 271 · scores higher than 93% of peers · safety percentile 92
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)27 peers with a safety percentile of 90–100, including RLAY · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RLAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 267 reported | 0.03× | 0.25× | 80% | 33% | |
| BetaLower is better · 266 reported | 1.70 | 0.55 | 9% | 33% | |
| Current ratioHigher is better · 261 reported | 18.27× | 2.44× | 95% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 2.2B USD | 99 | 48 | |
| 17 | 5.2B USD | 94 | 74 | |
| 18 | 3.0B USD | 93 | 54 | |
| 19 | 18.0B CNY (≈$2.5B) | 93 | 80 | |
| 20 | 15.6B DKK (≈$2.3B) | 93 | 96 | |
| 21 | 3.8B USD | 92 | 48 | |
| 22 | 2.8B USD | 92 | 51 | |
| 23 | 2.3B USD | 92 | 26 | |
| 24 | 5.4B USD | 91 | 38 | |
| 25 | 3.1B USD | 90 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score